|
1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ikai I, Arii S, Okazaki M, Okita K, Omata
M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, et
al: Report of the 17th Nationwide Follow-up Survey of Primary Liver
Cancer in Japan. Hepatol Res. 37:676–691. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT,
Tsai SF, Chen PJ and Lin CH: Chromosomal changes and clonality
relationship between primary and recurrent hepatocellular
carcinoma. Gastroenterology. 119:431–440. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nomoto S, Kinoshita T, Kato K, Otani S,
Kasuya H, Takeda S, Kanazumi N, Sugimoto H and Nakao A:
Hypermethylation of multiple genes as clonal markers in
multicentric hepatocellular carcinoma. Br J Cancer. 97:1260–1265.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang B, Xia CY, Lau WY, Lu XY, Dong H, Yu
WL, Jin GZ, Cong WM and Wu MC: Determination of clonal origin of
recurrent hepatocellular carcinoma for personalized therapy and
outcomes evaluation: A new strategy for hepatic surgery. J Am Coll
Surg. 217:1054–1062. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shindoh J, Hasegawa K, Matsuyama Y, Inoue
Y, Ishizawa T, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M and
Kokudo N: Low hepatitis C viral load predicts better long-term
outcomes in patients undergoing resection of hepatocellular
carcinoma irrespective of serologic eradication of hepatitis C
virus. J Clin Oncol. 31:766–773. 2013. View Article : Google Scholar
|
|
8
|
Cheng Z, Yang P, Qu S, Zhou J, Yang J,
Yang X, Xia Y, Li J, Wang K, Yan Z, et al: Risk factors and
management for early and late intrahepatic recurrence of solitary
hepatocellular carcinoma after curative resection. HPB Oxf.
17:422–427. 2015. View Article : Google Scholar
|
|
9
|
Iizuka N, Oka M, Yamada-Okabe H, Nishida
M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, et al:
Oligonucleotide microarray for prediction of early intrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Lancet. 361:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurokawa Y, Matoba R, Takemasa I, Nagano
H, Dono K, Nakamori S, Umeshita K, Sakon M, Ueno N, Oba S, et al:
Molecular-based prediction of early recurrence in hepatocellular
carcinoma. J Hepatol. 41:284–291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang SM, Ooi LL and Hui KM: Identification
and validation of a novel gene signature associated with the
recurrence of human hepatocellular carcinoma. Clin Cancer Res.
13:6275–6283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshioka S, Takemasa I, Nagano H, Kittaka
N, Noda T, Wada H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K,
et al: Molecular prediction of early recurrence after resection of
hepatocellular carcinoma. Eur J Cancer. 45:881–889. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yokoo H, Kondo T, Okano T, Nakanishi K,
Sakamoto M, Kosuge T, Todo S and Hirohashi S: Protein expression
associated with early intrahepatic recurrence of hepatocellular
carcinoma after curative surgery. Cancer Sci. 98:665–673. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan GS, Lim KH, Tan HT, Khoo ML, Tan SH,
Toh HC and Ching Ming Chung M: Novel proteomic biomarker panel for
prediction of aggressive metastatic hepatocellular carcinoma
relapse in surgically resectable patients. J Proteome Res.
13:4833–4846. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taoka M, Morofuji N, Yamauchi Y, Ojima H,
Kubota D, Terukina G, Nobe Y, Nakayama H, Takahashi N, Kosuge T, et
al: Global PROTOMAP profiling to search for biomarkers of
early-recurrent hepatocellular carcinoma. J Proteome Res.
13:4847–4858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaguchi H, Hasegawa K and Esumi M:
Protein from the fraction remaining after RNA extraction is useful
for proteomics but care must be exercised in its application. Exp
Mol Pathol. 95:46–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Esumi M, Ishibashi M, Yamaguchi H,
Nakajima S, Tai Y, Kikuta S, Sugitani M, Takayama T, Tahara M,
Takeda M, et al: Transmembrane serine protease TMPRSS2 activates
hepatitis C virus infection. Hepatology. 61:437–446. 2015.
View Article : Google Scholar
|
|
19
|
Yamaguchi H, Matsumoto S, Ishibashi M,
Hasegawa K, Sugitani M, Takayama T and Esumi M: β-Glucuronidase is
a suitable internal control gene for mRNA quantitation in
pathophysiological and non-pathological livers. Exp Mol Pathol.
95:131–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Numaguchi S, Esumi M, Sakamoto M, Endo M,
Ebihara T, Soma H, Yoshida A and Tokuhashi Y: Passive cigarette
smoking changes the circadian rhythm of clock genes in rat
intervertebral discs. J Orthop Res. 34:39–47. 2016. View Article : Google Scholar
|
|
21
|
Kim W, Oe Lim S, Kim JS, Ryu YH, Byeon JY,
Kim HJ, Kim YI, Heo JS, Park YM and Jung G: Comparison of proteome
between hepatitis B virus- and hepatitis C virus-associated
hepatocellular carcinoma. Clin Cancer Res. 9:5493–5500.
2003.PubMed/NCBI
|
|
22
|
Nurminskaya MV and Belkin AM: Cellular
functions of tissue transglutaminase. Int Rev Cell Mol Biol.
294:1–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naber HP, Drabsch Y, Snaar-Jagalska BE,
ten Dijke P and van Laar T: Snail and Slug, key regulators of
TGF-β-induced EMT, are sufficient for the induction of single-cell
invasion. Biochem Biophys Res Commun. 435:58–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Catalano V, Turdo A, Di Franco S, Dieli F,
Todaro M and Stassi G: Tumor and its microenvironment: A
synergistic interplay. Semin Cancer Biol. 23:522–532. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang L, Xu AM and Liu W: Transglutaminase
2 in cancer. Am J Cancer Res. 5:2756–2776. 2015.PubMed/NCBI
|
|
27
|
Shao M, Cao L, Shen C, Satpathy M,
Chelladurai B, Bigsby RM, Nakshatri H and Matei D:
Epithelial-to-mesenchymal transition and ovarian tumor progression
induced by tissue transglutaminase. Cancer Res. 69:9192–9201. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mangala LS, Fok JY, Zorrilla-Calancha IR,
Verma A and Mehta K: Tissue transglutaminase expression promotes
cell attachment, invasion and survival in breast cancer cells.
Oncogene. 26:2459–2470. 2007. View Article : Google Scholar
|
|
29
|
Verma A, Guha S, Wang H, Fok JY, Koul D,
Abbruzzese J and Mehta K: Tissue transglutaminase regulates focal
adhesion kinase/AKT activation by modulating PTEN expression in
pancreatic cancer cells. Clin Cancer Res. 14:1997–2005. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Agnihotri N, Kumar S and Mehta K: Tissue
transglutaminase as a central mediator in inflammation-induced
progression of breast cancer. Breast Cancer Res. 15:2022013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fang JH, Zhou HC, Zhang C, Shang LR, Zhang
L, Xu J, Zheng L, Yuan Y, Guo RP, Jia WH, et al: A novel vascular
pattern promotes metastasis of hepatocellular carcinoma in an
epithelial-mesenchymal transition-independent manner. Hepatology.
62:452–465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tatsukawa H, Furutani Y, Hitomi K and
Kojima S: Transglutaminase 2 has opposing roles in the regulation
of cellular functions as well as cell growth and death. Cell Death
Dis. 7:e22442016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xing M, Yang M, Huo W, Feng F, Wei L,
Jiang W, Ning S, Yan Z, Li W, Wang Q, et al: Interactome analysis
identifies a new paralogue of XRCC4 in non-homologous end joining
DNA repair pathway. Nat Commun. 6:62332015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Craxton A, Somers J, Munnur D, Jukes-Jones
R, Cain K and Malewicz M: XLS (c9orf142) is a new component of
mammalian DNA double-stranded break repair. Cell Death Differ.
22:890–897. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ochi T, Blackford AN, Coates J, Jhujh S,
Mehmood S, Tamura N, Travers J, Wu Q, Draviam VM, Robinson CV, et
al: DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku
to promote DNA double-strand break repair. Science. 347:185–188.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ramsey CS, Yeung F, Stoddard PB, Li D,
Creutz CE and Mayo MW: Copine-I represses NF-kappaB transcription
by endoproteolysis of p65. Oncogene. 27:3516–3526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xia Y, Shen S and Verma IM: NF-κB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu D, Wu P, Zhao L, Huang L, Zhang Z, Zhao
S and Huang J: NF-κB expression and outcomes in solid tumors: A
systematic review and meta-analysis. Medicine (Baltimore).
94:e16872015. View Article : Google Scholar
|
|
39
|
Ghanipour A, Jirström K, Pontén F,
Glimelius B, Påhlman L and Birgisson H: The prognostic significance
of tryptophanyl-tRNA synthetase in colorectal cancer. Cancer
Epidemiol Biomarkers Prev. 18:2949–2956. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Morita A, Miyagi E, Yasumitsu H, Kawasaki
H, Hirano H and Hirahara F: Proteomic search for potential
diagnostic markers and therapeutic targets for ovarian clear cell
adenocarcinoma. Proteomics. 6:5880–5890. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee CW, Chang KP, Chen YY, Liang Y, Hsueh
C, Yu JS, Chang YS and Yu CJ: Overexpressed tryptophanyl-tRNA
synthetase, an angiostatic protein, enhances oral cancer cell
invasiveness. Oncotarget. 6:21979–21992. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang C, Zhang Y, Guo K, Wang N, Jin H, Liu
Y and Qin W: Heat shock proteins in hepatocellular carcinoma:
Molecular mechanism and therapeutic potential. Int J Cancer.
138:1824–1834. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang RC, Huang CY, Pan TL, Chen WY, Ho CT,
Liu TZ and Chang YJ: Proteomic characterization of Annexin l (ANX1)
and heat shock protein 27 (HSP27) as biomarkers for invasive
hepatocellular carcinoma cells. PLoS One. 10:e01392322015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ishihama Y, Oda Y, Tabata T, Sato T,
Nagasu T, Rappsilber J and Mann M: Exponentially modified protein
abundance index (emPAI) for estimation of absolute protein amount
in proteomics by the number of sequenced peptides per protein. Mol
Cell Proteomics. 4:1265–1272. 2005. View Article : Google Scholar : PubMed/NCBI
|
